Pelvic Inflammatory Disease and Tubo-ovarian Abscess

Infectious Disease Clinics of North America

Volumn 22, Issue 4, 2008, Pages 693-708

  Lareau, Susan M ^a   Beigi, Richard H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ABDOMINAL HYSTERECTOMY; ABDOMINAL PAIN; ABSCESS DRAINAGE; ANAEROBE; ANTIBIOTIC THERAPY; BLOOD CELL COUNT; CHLAMYDIA TRACHOMATIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECTOPIC PREGNANCY; ENDOMETRIUM BIOPSY; FEMALE INFERTILITY; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; LOADING DRUG DOSE; MONOTHERAPY; NEISSERIA GONORRHOEAE; PATIENT COMPLIANCE; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PERIHEPATITIS; PHYSICAL EXAMINATION; PREVALENCE; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; REVIEW; SALPINGOOOPHORECTOMY; SCINTIGRAPHY; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SINGLE DRUG DOSE; TUBOOVARIAN ABSCESS; ULTRASOUND; UTERINE TUBE; VAGINA FLORA; VAGINA SMEAR;

ABSCESS; ADNEXAL DISEASES; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; NEISSERIA GONORRHOEAE; PELVIC INFLAMMATORY DISEASE; YOUNG ADULT;

EID: 54049113925     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2008.05.008     Document Type: Review

References (53)

1. Mardh P.-A., Lind I., Svensson L., et al. Antibodies to Chlamydia trachomatis, Mycoplasma hominis and Neisseria gonorrheoae in serum from patients with acute salpingitis. Br J Vener Dis 57 (1981) 125-129
2. Sweet R.L., Schachter J., and Robbie M.O. Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA 250 (1983) 2641-2645
3. Wasserheit J.N., Bell T.A., Kiviat N.B., et al. Microbiological causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 104 (1986) 187-193
4. Sweet R.L., Schachter J., Landers D.V., et al. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline. Am J Obstet Gynecol 158 (1988) 736-743
5. Rein D.B., Kassler W.J., Irwin K.L., et al. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol 95 (2000) 397-402
6. Washington A.E., Cates W., and Zadi A.A. Hospitalization for pelvic inflammatory disease. Epidemiology and trends in the United States, 1975 to 1981. JAMA 251 (1984) 2529-2533
7. Aral S.O., Mosher W.D., and Cates Jr. W. Self-reported pelvic inflammatory disease in the United States, 1988. JAMA 266 (1991) 2570-2573
8. Westrom L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 138 (1980) 880-892
9. STD Surveillance 2006. Available at:. http://www.cdc.gov/std/stats/tables/table42.htm Accessed February 14, 2008
10. Beigi R.H., and Wiesenfeld H.C. Pelvic inflammatory disease: new diagnostic criteria and treatment. Obstet Gynecol Clin North Am 30 (2003) 777-793
11. Sweet R.L. Pelvic inflammatory disease. In: Sweet R.L., and Gibbs R.S. (Eds). Infectious diseases of the female genital tract. 4th edition (2001), Lippincott Williams & Wilkins, Philadelphia 368-412
12. Jossens M.O., Eskenazi B., Schachter J., et al. Risk factors for pelvic inflammatory disease: a case-control study. Sex Transm Dis 23 (1996) 239-247
13. Scholes D., Daling J.R., Stergachis A., et al. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol 81 (1993) 601-606
14. Zhang J., Thomas G., and Leybovich E. Vaginal douching and adverse health effects. Am J Public Health 87 (1997) 1207-1211
15. Hillier S.L., Kiviat N.B., Hawes S.E., et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 175 (1996) 435-441
16. Jossens M.O., Schachter J., and Sweet R.L. Risk factors associated with pelvic inflammatory disease of differing microbial etiologies. Obstet Gynecol 83 (1994) 989-997
17. Sweet R.L. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 20 Suppl 2 (1995) S271-S275
18. Wiesenfeld H.C., and Sweet R.L. Progress in the management of tuboovarian abscess. Clin Obstet Gynecol 36 (1993) 433-444
19. Landers D.V., and Sweet R.L. Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis 5 (1983) 876-884
20. Grimes D.A. Deaths due to sexually transmitted diseases. JAMA 255 (1986) 1727-1729
21. Lopez-Zeno J.A., Keith L.G., and Berger G.S. The Fitz-Hugh-Curtis syndrome revisited: changing perspectives after half a century. J Reprod Med 30 (1985) 567-582
22. Yeh J., Hook III E., and Goldie S. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis 30 (2003) 369-378
23. Wiesenfeld H.C., Hillier S.L., Krohn M.A., et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 100 (2002) 456-463
24. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 55 No. RR-11 (2006) 1-77
25. Wolner-Hanssen P. Diagnosis of pelvic inflammatory disease. In: Landers D.V., and Sweet R.L. (Eds). Pelvic inflammatory disease (1997), Springer-Verlag, New York 60-75
26. Jacobson L., and Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 105 (1969) 1088-1098
27. Bongard F., Landers D.V., and Lewis F. Differential diagnosis of appendicitis and pelvic inflammatory disease. Am J Surg 150 (1985) 90-96
28. Eschenbach D.A. Epidemiology and diagnosis of acute pelvic inflammatory disease. Obstet Gynecol 55 (1980) 142S-152S
29. Kahn J.G., Walker C.K., Washington A.E., et al. Diagnosing pelvic inflammatory disease: a comprehensive analysis and considerations for developing a new model. JAMA 266 (1991) 2594-2604
30. Lehtinen M., Laine S., Heinonen P.K., et al. Serum C-reactive protein determination in acute pelvic inflammatory disease. Am J Obstet Gynecol 154 1 (1986) 158-159
31. Hemila M., Henrikson L., Ylikorkala O., et al. Serum CRP in the diagnosis and treatment of pelvic inflammatory disease. Arch Gynecol Obstet 241 (1987) 177-182
32. Yudin M.H., Hillier S.L., Wiesenfeld H.C., et al. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 188 (2003) 318-323
33. Peipert J.F., Boardman L., Hogan J.W., et al. Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol 87 (1996) 730-736
34. Timor-Tritsch I., Lerner J., Monteagudo A., et al. Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound Obstet Gynecol 12 (1998) 56-66
35. Cacciatore B., Leminem A., Ingman-Friberg S., et al. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol 80 (1992) 912-916
36. Boardman L.A., Peipert J.F., Brody J.M., et al. Endovaginal sonography for the diagnosis of upper genital tract infections. Obstet Gynecol 90 (1997) 54-57
37. Sellors J., Mahoney J., Goldsmith C., et al. The diagnosis of pelvic inflammatory disease: the accuracy of clinical and laparoscopic findings. Am J Obstet Gynecol 164 (1991) 113-120
38. Malhotra M., Sharma J.B., Batra S., et al. Ciprofloxacin-tinidazole combination, fluconazole-azithromycin-secnidazole-kit and doxycycline-metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. Indian J Med Sci 57 (2003) 549-555
39. Rustomjee R., Kharsany A.B., Connolly C.A., et al. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. J Antimicrob Chemother 49 (2002) 875-878
40. Savaris R.F., Teixeira L.M., Torres T.G., et al. Comparing ceftiraxone plus azithromycin or doxycycline for pelvic inflammatory disease. Obstet Gynecol 110 (2007) 53-60
41. Ness R.B., Soper D.E., Holley R.L., et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 186 5 (2002) 924-937
42. Ness R.B., Trautmann G., Richter H.E., et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 106 3 (2005) 573-580
43. Barbosa C., Milagros M., Brockmann S., et al. Pelvic inflammatory disease and human immunodeficiency virus infection. Obstet Gynecol 89 (1997) 65-70
44. Mugo N.R., Kiehlbauch J.A., Nguti R., et al. Effect of human immunodeficiency virus-1 infection of treatment outcome of acute salpingitis. Obstet Gynecol 104 4 (2006) 807-812
45. Sweet R.L. Anaerobic-aerobic pelvic infection and pelvic abscess. In: Sweet R.L., and Gibbs R.S. (Eds). Infectious diseases of the female genital tract. 4th edition (2001), Lippincott Williams & Wilkins, Philadelphia 189-206
46. McClean K.L., Sheehan G.J., and Harding G.K. Intraabdominal infection: a review. Clin Infect Dis 19 (1994) 100-116
47. Gagliardi P.D., Hoffer P.B., and Rosenfield A.T. Correlative imaging in abdominal infection: an algorithmic approach using nuclear medicine, ultrasound, and computed tomography. Semin Nucl Med 18 (1988) 320-334
48. Hiller N., Sella T., Lev-Sagi A., et al. Computed tomographic features of tuboovarian abscess. J Reprod Med 50 3 (2005) 203-208
49. Onderdonk A.B., Kasper D.L., Cisneros R.L., et al. The capsular polysaccharide of Bacterioides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis 136 (1977) 82-89
50. Reed S.D., Landers D.V., and Sweet R.L. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agent agents versus clindamycin-containing regimens. Am J Obstet Gynecol 164 (1991) 1556-1561
51. Pedowitz P., and Bloomfield R.D. Ruptured adnexal abscess (tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 88 (1964) 721-729
52. Hopkins G.B., Kan M., and Mende C.W. Gallium-67 scintography and intraabdominal sepsis: clinical experience in 140 patients with suspected intraabdominal abscess. West J Med 125 (1976) 425-430
53. Gjelland K., Ekerhovd E., and Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol 193 (2005) 1323-1330